BioWorld

Aug. 22, 2003

IPOs On The Rise: Nitromed, Pharmion, Acusphere On File

Three biotech companies recently have filed for initial public offerings in what appears to be a developing trend. (BioWorld Today) Read More

Cephalon's Hostile Takeover Bid For CIMA Ups The Ante

Two Human Immunities - Innate, Adaptive - Set Experimental Model To Mimic Multiple Sclerosis Course

Merck Options, Returns Aspects Of Vical's DNA Delivery Platform

BioStratum Opens Bridge Funding With $9.5M For Nephropathy Drug

CuraGen Subsidiary Sequences Whole Adenovirus In One Day

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for May 8, 2026.

Rendering of a key measles protein targeted by neutralizing human antibodies

First measles treatment advances as vaccination rates drop

BioWorld

Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...

Infensa Bioscience identifies new ASIC blockers

BioWorld Science

Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.

Hantavirus is ‘sentinel’ more than acute pandemic threat

BioWorld

News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...

Art concept for inflammation in the intestines

Kymera’s IRF5 degrader shows potential in IBD treatment

BioWorld Science

At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...